Switching from a vitamin K antagonist to a NOAC

被引：2
|
作者：
Senoo, Keitaro [1 ]
Lip, Gregory Y. H. [1 ,2 ]
机构：
[1] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham B18 7QH, W Midlands, England
[2] Aalborg Univ, Aalborg Thrombosis Res Unit, Dept Clin Med, Aalborg, Denmark
来源：
LANCET HAEMATOLOGY | 2015年 / 2卷 / 04期
关键词：
ATRIAL-FIBRILLATION; DABIGATRAN; ANTICOAGULATION; PREVENTION; WARFARIN; STROKE; EVENTS;
D O I：
10.1016/S2352-3026(15)00041-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E132 / E133
页数：2
相关论文
共 50 条
  • [31] Intraparenchymal hemorrhage following novel oral anticoagulant (NOAC) Or vitamin K antagonist (VKA) therapy: A systematic review and meta-analysis of clinical outcomes
    Yunusa, Ismaeel
    DiRisio, Aislyn C.
    Harary, Maya
    Muskens, Ivo S.
    Gormley, William B.
    Aglio, Linda S.
    Smith, Timothy R.
    Connors, Jean M.
    Mekary, Rania A.
    Broekman, Marike L. D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 468 - 469
  • [32] Relationship Amongst Vitamin K Status, Vitamin K Antagonist Use and Osteoarthritis: A Review
    Kok-Yong Chin
    Kok-Lun Pang
    Sok Kuan Wong
    Deborah Chia Hsin Chew
    Haji Mohd Saad Qodriyah
    Drugs & Aging, 2022, 39 : 487 - 504
  • [33] Relationship Amongst Vitamin K Status, Vitamin K Antagonist Use and Osteoarthritis: A Review
    Chin, Kok-Yong
    Pang, Kok-Lun
    Wong, Sok Kuan
    Chew, Deborah Chia Hsin
    Qodriyah, Haji Mohd Saad
    DRUGS & AGING, 2022, 39 (07) : 487 - 504
  • [34] Interaction of metformin with the vitamin K antagonist phenprocoumon
    Wijnen, J.
    Van de Riet, I
    Lijfering, W. M.
    Van der Meer, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 823 - 824
  • [35] Urgent reversal of vitamin K antagonist therapy
    Vang, M. L.
    Hvas, A. M.
    Ravn, H. B.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2011, 55 (05) : 507 - 516
  • [36] Commentary on variability in vitamin K antagonist metabolism
    Smith, Dennis A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (01) : 1 - 2
  • [37] Haematoma expansion and vitamin K antagonist reversal
    Zemrak, Wesley R.
    Smith, Kathryn E.
    Gagnon, David J.
    Rolfe, Stephen S.
    Seder, David B.
    LANCET NEUROLOGY, 2016, 15 (11): : 1116 - 1117
  • [38] Risk factors of vitamin K antagonist overcoagulation
    Marie, I.
    Leprince, P.
    Menard, J. -F.
    Tharasse, C.
    Levesque, H.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2012, 105 (01) : 53 - 62
  • [39] Tibolone + vitamin K antagonist treatment: overanticoagulation
    Reactions Weekly, 2004, 988 (1) : 5 - 5
  • [40] Switching to non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients taking vitamin K antagonists: a 1-year report of the SULTAN registry
    Rivera Caravaca, J. M.
    Marin, F.
    Esteve-Pastor, M. A.
    Ferreira, I.
    Badimon, L.
    Rafols, C.
    Ruiz-Ortiz, M.
    Anguita, M.
    EUROPEAN HEART JOURNAL, 2018, 39 : 822 - 823
12345